SCHEMBL27503586

SCHEMBL27503586

CCC(CC)C1CNCC(OC(=O)C(C)(C)C)C1c1ccc(Cl)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 4/20 0.33
SLC6A2 P23975 3/20 0.33
SLC6A3 Q01959 2/20 0.33
ABCC1 P33527 1/20 0.32
ELANE P08246 1/20 0.32
GAA P10253 2/20 0.32
ALOX12 P18054 2/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 2/20 0.32
ABCB11 O95342 1/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
HTR2A P28223 1/20 0.32
PMP22 Q01453 1/20 0.32
PPARA Q07869 1/20 0.32
SSTR4 P31391 1/20 0.31
KMT2A Q03164 2/20 0.31
NPC1 O15118 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27502568 0.87 KMT2A (0.35) SLC6A4SLC6A2SLC6A3ELANECYP1A2
SCHEMBL6042278 0.76 GBA1 (0.39) SLC6A4SLC6A2SLC6A3HTT
SCHEMBL27486781 0.70 SSTR4 (0.32) TSHRSSTR4HTT
SCHEMBL27503612 0.66 GBA1 (0.40) SLC6A4SLC6A2SLC6A3SSTR4KMT2A
SCHEMBL7560345 0.64 CHRM2 (0.39) GAAALOX12ALDH1A1CYP1A2CYP3A4
SCHEMBL6041390 0.64 CHRM2 (0.39) GAAALOX12ALDH1A1CYP1A2TSHR
SCHEMBL7074672 0.62 MDM2 (0.33) GAAALOX12ALDH1A1KMT2AMEN1
SCHEMBL27596960 0.62 SLC6A4 (0.62) SLC6A4SLC6A2SLC6A3ELANECYP1A2
SCHEMBL6041346 0.61 CCR1 (0.37)
SCHEMBL28286490 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1256326-C Novel 4- (oxoxyphenyl) -3-oxopiperidines for the treatment of cardiac and renal insufficiency HOFFMANN LA ROCHE (CH) 2006-05-17 CN disclosed
CN-1202152-A Novel 4- (oxoxyphenyl) -3-oxopiperidines for the treatment of cardiac and renal insufficiency HOFFMANN LA ROCHE (CH) 1998-12-16 CN disclosed